George Vasquez-Rios, MD, explains how the ASN's GD-C Compendium curates glomerular disease guidance for general clinicians and specialists alike.
News|Articles|December 17, 2025
The Lancet Commission on Obesity: Redefining Endocrinology’s Most Notorious Condition
Author(s)Ryan Livingston
Fact checked by: Patrick Campbell
Experts redefine obesity, distinguishing between preclinical and clinical forms, aiming to improve diagnosis and treatment strategies for better health outcomes.
Advertisement
Advertisement
Obesity is a worldwide epidemic, affecting 1 in 8 people worldwide in 2022. Worldwide adult obesity has more than doubled since 1990, with 2.5 billion adults overweight and 890 of these living with obesity in 2022. Additionally, 43% of adults ≥18 years were overweight in 2022, and 16% were living with obesity. In 2024, 35 million children <5 years were overweight.1
Related to this article
Andrew Cutler, MD, says real-world MDD patients respond to adjunctive cariprazine like trial participants, with gains in mood and function within weeks.
Frances Lee, MD, on the stigma driving under-detection of ALD and its disproportionate rise in women and younger adults.
SOCS leaders explain SOCS Serves, a toolkit-based program connecting dermatology volunteers with students and underserved communities.
EMBARQ-CSU1 and EMBARQ-CSU2 showed sustained reductions in urticaria, with the antibody meeting all primary and key secondary endpoints at Week 12.
The FDA-approved update adds phase 3 HYPERION data on adults diagnosed with PAH within the past year.
Josh Woolley, MD, PhD, explains why current active placebos fail to mask high-dose psilocybin trials and outlines a framework proposed to fix it.
Raj Chovatiya, MD, PhD, on zasocitinib results in the scalp, nails, palms and soles, speed of response and once-daily oral dosing in psoriasis.
Advertisement
Advertisement